SHANGHAI, February 20, 2025 — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading digital healthcare platform in China, will release its unaudited financial results for Q4 and fiscal year 2024 (ending December 31, 2024) before the U.S. market opens on March 20, 2025.

111’s leadership will host an earnings call at 7:30 AM ET on March 20, 2025 (7:30 PM Beijing Time).

Conference details:

Topic: 111, Inc. Q4 and Fiscal Year 2024 Earnings Conference Call
Registration Link:

Pre-registration via the link is required. Registered participants will receive dial-in information (number, passcode, PIN) via email and calendar invite.

Please dial in 15 minutes early. To join, dial the number in your invite, enter the passcode and PIN.

A live and archived webcast will be accessible on the company website at .

A telephone replay will be available until March 27, 2025.

China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10045645

About 111, Inc.

111, Inc. (NASDAQ: YI) is a prominent tech-enabled healthcare platform company dedicated to transforming China’s healthcare value chain through digital empowerment. It offers improved access to pharmaceutical products and healthcare services via its online retail pharmacy (1 Pharmacy), offline virtual pharmacy network, online healthcare services (1 Clinic), and a B2B platform (1 Medicine) for pharmacies. With China’s largest virtual pharmacy network, 111 provides cloud services to offline pharmacies. It also offers an omni-channel drug commercialization platform to partners, including services like digital marketing and data analytics.

For more information on 111, please visit: .

SOURCE 111, Inc.